Patents, Trademarks, Trade Secrets, and Copyrights Oh My!


Amgen seeks to intervene in biosimilar patent case

"Amgen Inc. urged a federal judge to unseal scores of documents in Regeneron Pharmaceuticals Inc.’s patent-infringement suit over Viatris Inc.’s proposed biosimilar version of Eylea, saying the public has a right to access filings."
Bloomberg Law
2023-05-25 05:36:39